News
COCH
0.7000
-0.43%
-0.0030
Envoy Medical files to sell Class A common stock, no amount given
TipRanks · 15h ago
Envoy Medical Announces Its Pivotal Clinical Trial For Acclaim Cochlear Implant Reaches Midway Point Of Study's Full Enrollment Program
Benzinga · 1d ago
Envoy Medical Hits Enrollment Milestone in Pivotal Acclaim Cochlear Implant Trial
Reuters · 1d ago
Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
Newsfile · 1d ago
Envoy Medical Updates Investors on Strategic Plans
TipRanks · 2d ago
Envoy Medical Secures Australian Patent for Fully Implanted Cochlear Implant Innovation
Reuters · 3d ago
Weekly Report: what happened at COCH last week (1208-1212)?
Weekly Report · 4d ago
Envoy Medical Announces Completion Of First Set Of Activations In Final Stage Of Pivotal Clinical Study For Investigational Fully Implanted Acclaim Cochlear Implant
Benzinga · 12/10 13:11
Envoy Medical Activates First Patients in Pivotal Trial of Fully Implanted Acclaim Cochlear Implant
Reuters · 12/10 13:01
Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant
Newsfile · 12/10 13:00
Weekly Report: what happened at COCH last week (1201-1205)?
Weekly Report · 12/08 10:28
Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient
Newsfile · 12/04 13:00
Envoy Medical Stockholders Approve Warrant Issuance
TipRanks · 12/03 21:36
Envoy Medical Inc. Held Special Meeting of Stockholders
Reuters · 12/03 21:02
Envoy Medical, Inc. (COCH) Upgraded to Buy: Here's Why
NASDAQ · 12/03 17:00
Envoy Medical Inc. Granted 40th U.S. Patent for Fully Implanted Hearing Device Technology
Reuters · 12/02 13:03
Envoy Medical Announces the Grant of Its 40th U.S. Patent
Newsfile · 12/02 13:00
Weekly Report: what happened at COCH last week (1124-1128)?
Weekly Report · 12/01 10:23
Envoy Medical Faces Nasdaq Delisting Notice
TipRanks · 11/25 21:35
Envoy Medical Faces Nasdaq Delisting Risk Over Minimum Bid Price Compliance
Reuters · 11/25 21:02
More
Webull provides a variety of real-time COCH stock news. You can receive the latest news about Envoy Medical through multiple platforms. This information may help you make smarter investment decisions.
About COCH
Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.